MRI-guided focused ultrasound devices market seen reaching $5.43 billion by 2030

The market for MRI-guided and focused ultrasound devices is projected to grow from $3.14 billion in 2025 to $5.43 billion by 2030, driven by demand for non-invasive treatment and more advanced image-guided therapies. North America held the largest share in 2025, while Asia-Pacific is expected to grow the fastest.

Why it matters: - MRI-guided focused ultrasound devices combine imaging and therapy in a non-invasive format that can reduce the need for traditional surgery. - The technology is gaining ground as health systems look for more precise treatment options for neurological disorders, cancer-related conditions and outpatient care. - The market forecast points to sustained demand, with a projected 11.5% CAGR through 2030.

What happened: - The Business Research Company released a report on the MRI-guided and focused ultrasound devices market covering market size, trends and a global forecast from 2026 to 2035. - The market is projected to rise from $3.14 billion in 2025 to $3.51 billion in 2026. - The market is expected to reach $5.43 billion by 2030. - The report was published in London on Aug. 14, 2026. - The company offered a free sample of the report. - The company also made the full report available online.

The details: - The market grew at a 11.8% CAGR in the historical period described in the report. - Growth drivers include minimally invasive procedures, better MRI resolution, more cancer cases, wider use of image-guided therapies and clinical validation of focused ultrasound. - Forecast growth is tied to non-invasive neurosurgical treatments, AI for therapy management, outpatient care demand, precision medicine investment and broader regulatory approvals. - Expected trends include MRI-guided non-invasive therapies, AI-assisted treatment planning, real-time image-guided precision ablation, integrated imaging-and-therapy platforms and data-driven outcome monitoring. - MRI-guided focused ultrasound systems use MRI to continuously monitor the treatment area while high-intensity focused ultrasound delivers energy to targeted tissue. - The approach is designed to limit damage to surrounding healthy tissue. - Neurological disorders are a major demand driver because the devices support diagnosis and treatment with real-time imaging and non-invasive therapy. - The report cites National Health Service data showing 487,432 dementia cases in the UK as of June 30, 2024, up 3,155 from the prior month. - In 2025, North America held the largest share of the global market. - Asia-Pacific is expected to grow the fastest over the forecast period. - The regional analysis also covers South East Asia, Western Europe, Eastern Europe, South America, the Middle East and Africa. - The 2026 reports include market attractiveness scoring, TAM analysis, company scoring matrix graphics and tables, Excel-based forecasting dashboards, market hotspots infographics, key technologies and future trend analysis, plus updated graphics and tables.

Between the lines: - The report frames the category as moving from a niche therapeutic tool toward a broader platform for precision care. - AI and integrated imaging-therapy systems suggest the market is shifting toward workflow automation and more standardized treatment planning. - The regional split implies mature adoption in North America and faster expansion opportunities in Asia-Pacific.

What's next: - The market is expected to keep expanding through 2030 as regulatory approvals broaden and more clinical use cases emerge. - Adoption will likely track progress in non-invasive neurosurgery, outpatient treatment models and precision medicine investment. - The company invited readers to contact Saumya Sahay for more information and follow its social channels, including LinkedIn.